Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Adult Congenital Heart Disease, Congenital Heart Disease, PTSD
Interventions: Other; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Lebanon, New Hampshire • Columbus, Ohio

Conditions: Breast Cancer, Ductal Carcinoma In Situ
Interventions: Survey Assessments, Diet Recall, Blood Biomarker Collection; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Solid Tumor, Childhood, Solid Tumor
Interventions: Eltrombopag; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 1 Year to 18 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Nutritional Assessment
Interventions: Validation of the PortionSize app; Device
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 7 Years to 12 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Type-2 Diabetes
Interventions: vildagliptin; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 5
States / cities: Miami, Florida • Orlando, Florida • Minneapolis, Minnesota + 2 more

Conditions: Normal Physiology
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2041
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity
Interventions: referral to comprehensive weight management clinic; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Prostate Carcinoma
Interventions: Biospecimen Collection; Procedure
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 50 Years to 79 Years · Male only
Enrollment: 810 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Geographic Atrophy (GA)
Interventions: Pozelimab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 50 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Lakewood, Colorado • East Weymouth, Massachusetts • Austin, Texas + 2 more

Conditions: Acute Hypoxemic Respiratory Failure
Interventions: Lucinactant, Sham Comparator; Drug · Other
Lead sponsor: Windtree Therapeutics; Industry
Eligibility: Up to 2 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Warrington, Pennsylvania

Conditions: Achondroplasia
Interventions: Navepegritide, Placebo for Navepegritide; Drug
Lead sponsor: Ascendis Pharma A/S; Industry
Eligibility: 0 Years to 2 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Saint Paul, Minnesota • Houston, Texas • Madison, Wisconsin

Conditions: GERD
Interventions: Concurrent manometry/impedance/pH with video pharyngo-laryngoscopy, Slow and rapid intra-esophageal infusion; Diagnostic Test
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Neovascular (Wet) AMD
Interventions: ABI-110 Low Dose, ABI-110 Medium Dose, ABI-110 High Dose; Drug
Lead sponsor: Avirmax Biopharma Inc; Industry
Eligibility: 50 Years to 89 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 4
States / cities: Bakersfield, California • Walnut Creek, California • San Antonio, Texas + 1 more

Conditions: Healthy
Interventions: Typhoid Vi Polysaccharide Vaccine, Placebo; Biological
Lead sponsor: University of California, San Francisco; Other
Eligibility: 30 Years to 60 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Influenza, Human
Interventions: mRNA Seasonal Flu vaccine, Licensed Influenza Vaccine; Combination Product
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 65 Years and older
Enrollment: 54,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 161
States / cities: Anniston, Alabama • Guntersville, Alabama • Glendale, Arizona + 128 more

Conditions: Stress Urinary Incontinence, Intrinsic Sphincter Deficiency
Interventions: Prefyx PPS™ System, Advantage ™ System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Chronic Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Large Granulocytic Leukemia
Interventions: Allogeneic transplantation; Procedure
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years to 69 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Spinal Muscular Atrophy
Interventions: Risdiplam; Drug
Lead sponsor: Bakri Elsheikh; Other
Eligibility: 18 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cutaneous Melanoma
Interventions: Demographics Questionnaire, Adjuvant Treatment Beliefs Scale10, Functional Assessment of Cancer Therapy - Melanoma (FACT-M)11, Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - General (FACIT-TS-G)13, Decisional Regret14, Clinician Preference for Treatment; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Basking Ridge, New Jersey • Harrison, New York • New York, New York

Conditions: Diabetes Mellitus, Type II
Interventions: Fenofibrate; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Primary Glioblastoma
Interventions: 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 200 J/cm^2, 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 400 J/cm^2; Combination Product
Lead sponsor: Hemerion Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Retina Pathology
Interventions: Dream OCT; Device
Lead sponsor: Intalight, Inc; Industry
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Trauma Injury
Interventions: Immunofluorescence Imaging, DCE-MRI; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: Irvine, California • Baltimore, Maryland • Boston, Massachusetts + 1 more

Conditions: Central Nervous System Diseases, Pediatric Disorder, Body Indication
Interventions: Gadopiclenol; Drug
Lead sponsor: Guerbet; Industry
Eligibility: Up to 23 Months
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Cincinnati, Ohio • Charleston, South Carolina

Search by objective public record fields.

Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors

Validity of the PortionSize App to Measure Children's Food Intake

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects

Inpatient Referral to Comprehensive Weight Management for Patients With Obesity

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

Mechanisms Preventing Pharyngeal Reflux

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Cognitive, Emotional, and Neural Responses to Acute Inflammation

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence

Unrelated Donor Stem Cell Transplantation

Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration

A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery

Fenofibrate in Type 2 Diabetes

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA Images

ICG Fluorescence Imaging in Post-traumatic Infection

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age